The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $72.36

Today's change-0.06 -0.08%
Updated December 5 4:15 PM EST. Delayed by at least 15 minutes.
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $72.36

Today's change-0.06 -0.08%
Updated December 5 4:15 PM EST. Delayed by at least 15 minutes.

Gilead Sciences Inc down slightly

Gilead Sciences Inc closed down just (U.S.)$0.06 Monday to (U.S.)$72.36. Over the last five days, shares have lost 2.92% and sit 1.36% above their 52-week low. This security has underperformed the S&P 500 by 35.87% during the last year.

Key company metrics

  • Open(U.S.) $72.79
  • Previous close(U.S.) $72.42
  • High(U.S.) $72.97
  • Low(U.S.) $71.93
  • Bid / Ask(U.S.) $72.35 / (U.S.) $72.48
  • YTD % change-28.49%
  • Volume9,985,859
  • Average volume (10-day)7,772,385
  • Average volume (1-month)9,733,897
  • Average volume (3-month)9,861,583
  • 52-week range(U.S.) $71.39 to (U.S.) $104.79
  • Beta1.23
  • Trailing P/E6.71×
  • P/E 1 year forward6.31×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.88
  • Dividend yield2.60%
  • Trailing EPS(U.S.) $10.78
Updated December 5 4:15 PM EST. Delayed by at least 15 minutes.
S&P TSX0.28%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue7,5007,7767,7948,506
Total other revenue--------
Total revenue7,5007,7767,7948,506
Gross profit6,3716,9126,6017,444
Total cost of revenue1,1298641,1931,062
Total operating expense3,1013,2383,1432,885
Selling / general / administrative8318906851,066
Research & development1,1411,4841,265757
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income4,3994,5384,6515,621
Interest income (expense), net non-operating-242-227-230-230
Gain (loss) on sale of assets--------
Other--------
Income before tax4,2764,3994,5025,437
Income after tax3,3253,4973,5674,685
Income tax, total951902935752
Net income3,3303,4973,5664,683
Total adjustments to net income--------
Net income before extra. items3,3303,4973,5664,683
Minority interest50-1-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,3303,4973,5664,683
Inc. avail. to common incl. extra. items3,3303,4973,5664,683
Diluted net income3,3303,4973,5664,683
Dilution adjustment0000
Diluted weighted average shares1,3391,3551,4121,470
Diluted EPS excluding extraordinary itemsvalue per share2.492.582.533.19
Dividends per sharevalue per share0.470.470.430.43
Diluted normalized EPSvalue per share2.492.582.533.19